An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ANTX | INTS | RAPT | ||
Company | An2 Therapeutics Inc | Intensity Therapeutics Inc | Rapt Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.2600 | 2.74 | 1.0400 | ||
High | 1.4194 | 2.86 | 1.1200 | ||
Low | 1.2600 | 2.65 | 1.0400 | ||
Last | 1.3400 | 2.86 | 1.1000 | ||
Change | +0.1100 | +0.16 | +0.0500 | ||
% Change | +8.94% | +5.98% | +4.76% | ||
Volume | 995,165 | 24,088 | 328,300 | ||
20-Day Average Volume | 1,009,877 | 17,079 | 1,113,338 | ||
Previous Close | 1.2300 | 2.70 | 1.0500 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 1.1007 | 3.14 | 1.8375 | ||
20-Day Raw Stochastic | 74.23% | 40.16% | 4.53% | ||
20-Day Relative Strength | 65.81% | 38.43% | 37.24% | ||
Weighted Alpha | -34.37 | -53.77 | -51.66 | ||
Today's Opinion | 40% Sell | 100% Sell | 100% Sell | ||
Previous Opinion | 40% Sell | 100% Sell | 88% Sell | ||
Last Month's Opinion | 72% Sell | 100% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +33.50% since 11/15/24 | -9.16% since 11/15/24 | unch since 11/15/24 | ||
Low | 0.9750 on 11/18/24 | 2.50 on 11/21/24 | 1.0000 on 11/21/24 | ||
High | 1.4600 on 11/21/24 | 3.15 on 11/18/24 | 1.2200 on 11/18/24 | ||
1-Month | |||||
%Chg | +23.61% since 10/22/24 | -14.59% since 10/22/24 | -38.27% since 10/22/24 | ||
Low | 0.9750 on 11/18/24 | 2.50 on 11/21/24 | 1.0000 on 11/21/24 | ||
High | 1.4600 on 11/21/24 | 3.40 on 11/04/24 | 3.3200 on 11/06/24 | ||
3-Month | |||||
%Chg | +20.27% since 08/22/24 | -32.91% since 08/22/24 | -51.96% since 08/22/24 | ||
Low | 0.9750 on 11/18/24 | 2.50 on 11/21/24 | 1.0000 on 11/21/24 | ||
High | 1.4600 on 11/21/24 | 4.35 on 09/03/24 | 3.3200 on 11/06/24 | ||
6-Month | |||||
%Chg | -37.03% since 05/22/24 | -42.77% since 05/22/24 | -76.13% since 05/22/24 | ||
Low | 0.8700 on 08/09/24 | 2.50 on 11/21/24 | 1.0000 on 11/21/24 | ||
High | 3.0700 on 07/17/24 | 5.10 on 07/11/24 | 4.7400 on 05/23/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 36,751 | 37,444 | 36,706 | ||
Shares Outstanding, K | 29,879 | 13,868 | 34,958 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -64,730,000 | -10,540,000 | -116,800,000 | ||
Last Quarter Sales | 0 | 0 | 0 | ||
Last Quarter Net Income | -12,750,000 | -3,510,000 | -18,430,000 | ||
60-Month Beta | -0.22 | 4.01 | 0.33 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.43 on 11/13/24 | -0.25 on 11/13/24 | -0.47 on 11/12/24 | ||
Latest Earnings Date | 11/14/24 | 11/11/24 | 11/11/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |